ResMed Balance Sheet Health
Financial Health criteria checks 6/6
ResMed has a total shareholder equity of $5.2B and total debt of $677.5M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are $7.2B and $2.0B respectively. ResMed's EBIT is $1.5B making its interest coverage ratio 41. It has cash and short-term investments of $442.6M.
Key information
13.0%
Debt to equity ratio
US$677.47m
Debt
| Interest coverage ratio | 41x |
| Cash | US$442.58m |
| Equity | US$5.20b |
| Total liabilities | US$2.03b |
| Total assets | US$7.22b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RME's short term assets ($2.6B) exceed its short term liabilities ($904.1M).
Long Term Liabilities: RME's short term assets ($2.6B) exceed its long term liabilities ($1.1B).
Debt to Equity History and Analysis
Debt Level: RME's net debt to equity ratio (4.5%) is considered satisfactory.
Reducing Debt: RME's debt to equity ratio has reduced from 57.6% to 13% over the past 5 years.
Debt Coverage: RME's debt is well covered by operating cash flow (212.6%).
Interest Coverage: RME's interest payments on its debt are well covered by EBIT (41x coverage).